You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 24, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Kristina Lindgren1, Andréa Salmén, Mats Lundgren
1BioProcess R&D, AstraZeneca (now Recipharm Biologics AB), Gärtunavägen 10, 152 57, Södertälje, Sweden.
Automated cell line development for biopharmaceuticals increases throughput and reduces costs. This robotic system produces high-quality cell lines comparable to manual methods, enhancing production capacity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: